Benzonatate Capsule
Product Images NDC 72789-232

2 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 72789-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Formula (Structure Formula)

Structure Formula (Structure Formula)
Chemical structure of Benzonatate (C30H53NO11) showing its molecular components and arrangement, as depicted on the diagram.*
FDA Label Image

72789232 Label (72789232)

72789232 Label (72789232)
Label for Benzonatate USP 200 mg capsules, containing 30 capsules per bottle. The label includes warnings to keep out of reach of children, dosing instructions with blank spaces for prescription details, and batch information including lot number B22A79 and expiration date 02/2024. Manufactured by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.